Trial Profile
Safety and efficacy if fidaxomicin in patients with clostridium difficile infection: A real-world retrospective observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jan 2021
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2021 Results assessing main risk factors of recurrence after treatment with fidaxomicin, published in the Infection.
- 02 May 2018 New trial record
- 24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases